Showing results (101-110 of 181) with videos related to

Sort By:
Pageof 19
Diabetes/Metabolism Research and Reviews|March 18, 2017
Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β indexRiccardo C Bonadonna, Lawrence Blonde, Mikhail Antsiferov, et al.
The American Journal of Managed Care|February 12, 2014
Attainment of diabetes-related quality measures with canagliflozin versus sitagliptinRobert A Bailey, C V Damaraju, Silas C Martin, et al.
Proceedings. Biological Sciences|February 12, 2016
Niche-tracking migrants and niche-switching residents: evolution of climatic niches in New World warblers (Parulidae)Camila Gómez, Elkin A Tenorio, Paola Montoya, et al.
BMC Ecology and Evolution|August 2, 2022
Environmental niche and flight intensity are associated with molecular evolutionary rates in a large avian radiationPaola Montoya, Carlos Daniel Cadena, Santiago Claramunt, et al.
Nature|November 4, 2005
Ecology: is speciation driven by species diversity?Carlos Daniel Cadena, Robert E Ricklefs, Iván Jiménez, et al.
Hormones and Behavior|April 27, 2024
Does testosterone underly the interplay between male traits and territorial behavior in neotropical poison frogs?Mileidy Betancourth-Cundar, Virginie Canoine, Leonida Fusani, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 21, 2018
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal InsulinLawrence Blonde, Denis Raccah, Elisheva Lew, et al.
Diabetes Spectrum : a Publication of the American Diabetes Association|June 7, 2019
Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical PracticeLawrence Blonde, Stephen A Brunton, Pavan Chava, et al.
Lancet (London, England)|June 12, 2009
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)John B Buse, Julio Rosenstock, Giorgio Sesti, et al.
The Journal of Clinical Psychiatry|April 26, 2008
Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of careLawrence Blonde, Hong J Kan, Elane M Gutterman, et al.
Pageof 19